Patent 7855291 was granted and assigned to Lexicon Pharmaceuticals, Inc. on December, 2010 by the United States Patent and Trademark Office.
Intermediates and synthetic processes for the preparation of substituted phenylalanine-based compounds (e.g., of Formula I) are disclosed: